Literature DB >> 21629254

Is RNAi dead?

Arthur M Krieg.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21629254      PMCID： PMC3129789          DOI： 10.1038/mt.2011.94

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  12 in total

1.  Gene delivery: Designer DNA give RNAi more spine.

Authors:  Dhiraj Bhatia; Saikat Chakraborty; Yamuna Krishnan
Journal:  Nat Nanotechnol       Date:  2012-06-03       Impact factor: 39.213

2.  Improved asymmetry prediction for short interfering RNAs.

Authors:  Amanda P Malefyt; Ming Wu; Daniel B Vocelle; Sean J Kappes; Stephen D Lindeman; Christina Chan; S Patrick Walton
Journal:  FEBS J       Date:  2014-01       Impact factor: 5.542

3.  ENDOCYTOSIS PATHWAYS FOR NUCLEIC ACID THERAPEUTICS.

Authors:  Amanda P Malefyt; S Patrick Walton; Christina Chan
Journal:  Nano Life       Date:  2012-09-01

Review 4.  Progress in microRNA delivery.

Authors:  Yu Zhang; Zaijie Wang; Richard A Gemeinhart
Journal:  J Control Release       Date:  2013-09-25       Impact factor: 9.776

Review 5.  RNA therapeutics: beyond RNA interference and antisense oligonucleotides.

Authors:  Ryszard Kole; Adrian R Krainer; Sidney Altman
Journal:  Nat Rev Drug Discov       Date:  2012-01-20       Impact factor: 84.694

6.  Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.

Authors:  Jesper B Bramsen; Jørgen Kjems
Journal:  Front Genet       Date:  2012-08-20       Impact factor: 4.599

7.  Non-Small-Cell Lung Cancer Regression by siRNA Delivered Through Exosomes That Display EGFR RNA Aptamer.

Authors:  Zhefeng Li; Linlin Yang; Hongzhi Wang; Daniel W Binzel; Terence M Williams; Peixuan Guo
Journal:  Nucleic Acid Ther       Date:  2021-05-17       Impact factor: 4.244

Review 8.  The notorious R.N.A. in the spotlight - drug or target for the treatment of disease.

Authors:  Philipp Reautschnig; Paul Vogel; Thorsten Stafforst
Journal:  RNA Biol       Date:  2016-07-14       Impact factor: 4.652

9.  Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus.

Authors:  Byungji Kim; Hong-Bo Pang; Jinyoung Kang; Ji-Ho Park; Erkki Ruoslahti; Michael J Sailor
Journal:  Nat Commun       Date:  2018-05-17       Impact factor: 14.919

10.  Induced-Decay of Glycine Decarboxylase Transcripts as an Anticancer Therapeutic Strategy for Non-Small-Cell Lung Carcinoma.

Authors:  Jing Lin; Jia Hui Jane Lee; Kathirvel Paramasivam; Elina Pathak; Zhenxun Wang; Zacharias Aloysius Dwi Pramono; Bing Lim; Keng Boon Wee; Uttam Surana
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.